Anaphylaxis, with bronchospasm, laryngeal edema, and dyspnea are rare reactions with an approximate frequency of about 1/5000 tests (1); they are treated with inhaled albuterol or subcutaneous 1: 1000 epinephrine 0.3 to 0.4 mL.